Navigation Links
PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
Date:9/24/2007

ANNAPOLIS, Md., Sept. 24 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: PIP), a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological terrorism, announced today the Department of Health and Human Services has published an award notice, dated September 21, 2007, in the amount of $13,920,347, listing PharmAthene as the contractor, relating to the development of therapeutic agents for selected bacterial diseases. PharmAthene has not received an executed agreement from the Department of Health and Human Services and expects to provide further information if and when such an executed agreement is received.

About PharmAthene, Inc.

PharmAthene (Amex: PIP) was formed to meet the critical needs of the United States and its Allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene's lead programs include Valortim(TM) for the prevention and treatment of anthrax infection and Protexia(R) for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents. For more information on PharmAthene, please visit http://www.PharmAthene.com.


'/>"/>
SOURCE PharmAthene, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Bruce Maas named CIO at UW-Milwaukee
2. Three finalists named for UW-Madison CIO
3. Eight lawmakers named to Speakers IT task force
4. Hospital named for Madame Curie installs TomoTherapy system
5. Two UW-Madison professors named to National LambdaRail Networking Research Council
6. UW researcher named top innovator
7. Alzheimers drug firm and more winners named in Wisconsin business-plan contest
8. Inacom named Microsofts favorite learning solutions partner of the year
9. Five Wisconsin CIOs named top in nation
10. Deltanoid named to top-15 list of biotech companies
11. Venture Investors early-stage fund grows to $115 million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/19/2020)... FREDERICK, Md. (PRWEB) , ... ... ... announces a clinical supply and manufacturing collaboration agreement with pioneering gene circuit ... gene-modified cell therapies for ovarian cancer and other solid tumor indications. The ...
(Date:3/10/2020)... , ... March 10, 2020 , ... Ortho Clinical Diagnostics, ... innovative laboratory solutions, announced its ORTHOTM Sera, ID-MTS, a suite of extended antigen in ... is cleared to run on ORTHO VISION® and ORTHO VISION® Max in the United ...
(Date:3/4/2020)... ... March 04, 2020 , ... This month, Cognosante will make its ... company will showcase both expanded and emerging offerings that align with the HIMSS annual ... designed to be comprehensive, timely, and engaging. From Interoperability and HIE ...
(Date:2/28/2020)... ... February 26, 2020 , ... Designed ... high-speed camera with a dedicated controller, thus simplifying setup, streamlining integration, and optimizing ... is the first of Fastec Imaging’s new HS Series cameras to be released. ...
Breaking Biology Technology:
(Date:3/3/2020)... ... ... Amplify Surgical, Inc., today announces that the company reached the milestone of ... The landmark case was performed by Dr. Ali Najafi at Fresno Heart and Surgical ... changed the game for expandable interbodies. The ability to achieve an ALIF sized ...
(Date:3/2/2020)... ... March 02, 2020 , ... Toronto-based clinical research organization (CRO) and regulatory ... office location just 5 minutes south of Clarksburg on a farm on Beaver Valley ... End of the Rainbow Orchard, and decided it would be a great new option ...
(Date:3/2/2020)... ... March 02, 2020 , ... Nominations are now being accepted ... the Security Industry Association (SIA) and SecureIDNews and co-presented with ... Security Forum . The recipients of this year’s Women in Biometrics Awards will be ...
Breaking Biology News(10 mins):